Arkolith/Insider Trading/ARWR/Form 4

Apel Daniel Joseph

Chief Financial OfficerARROWHEAD PHARMACEUTICALS, INC. (ARWR) · full profile →Form 4 · filed Apr 24, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$934K
Net Open-Market Flow
-$934K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 22, 2026Sell(S)3K$70.11$225K173K
Apr 22, 2026Sell(S)1K$70.45$82K172K
Apr 22, 2026Sell(S)9K$71.92$628K163K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000879407-26-000039) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML